stockrowAbbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +142.7%
Quarter to September 2026, against a year earlier
Follow ABT
Alert me
Abbott Laboratories (ABT) Return on invested capital
Abbott Laboratories's return on invested capital over the twelve months to 30 September 2026 was 0.00%, down 8.9 percentage points from fiscal 2025 (8.87%). Over the past ten years it has ranged from 1.99% (fiscal 2017) to 12.0% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −5.27% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 8.87% | 0.98 |
| FY2024 | 7.89% | (0.87) |
| FY2023 | 8.76% | (3.25) |
| FY2022 | 12.0% | (0.01) |
| FY2021 | 12.0% | 4.48 |
| FY2020 | 7.54% | 1.26 |
| FY2019 | 6.28% | 1.32 |
| FY2018 | 4.96% | 2.97 |
| FY2017 | 1.99% | (6.37) |
| FY2016 | 8.36% | (0.14) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| DXCM DexCom, Inc. compare | 39.0% |
| SYK Stryker Corporation compare | 9.67% |
| GEHC GE HealthCare Technologies Inc. compare | 8.86% |
| STE STERIS plc compare | 8.47% |
| EW Edwards Lifesciences Corporation compare | 7.79% |
| BSX Boston Scientific Corporation compare | 6.60% |
| PHG Koninklijke Philips N.V. compare | 6.15% |
| MDT Medtronic PLC compare | 6.04% |
| ABT Abbott Laboratories | 0.00% |
| Medical Devices industry median | −5.27% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement